Although ANXA3 is highly expressed in grade 1 and 2 meningioma tissues as observed by Western blot analysis (Fig. 7a), the NF2 phenotype, characterised by loss of function due to mutations, truncations, and/or deletions, is frequently observed in higher-grade meningiomas or more advanced molecular groups.8 Here, ANXA3 is linked to meningioma.